Skip to main content

Peer Review reports

From: Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa

Original Submission
22 Dec 2020 Submitted Original manuscript
8 Apr 2021 Reviewed Reviewer Report
10 Jun 2021 Reviewed Reviewer Report - Susan Cleary
23 Jul 2021 Author responded Author comments - Sylvie Boyer
Resubmission - Version 2
23 Jul 2021 Submitted Manuscript version 2
14 Sep 2021 Reviewed Reviewer Report - Susan Cleary
26 Oct 2021 Author responded Author comments - Sylvie Boyer
Resubmission - Version 3
26 Oct 2021 Submitted Manuscript version 3
Publishing
12 Nov 2021 Editorially accepted
5 Mar 2022 Article published 10.1186/s12913-021-07289-0

You can find further information about peer review here.

Back to article page